Rally wants to raise $100,000 to build a bridge to a Phase 2 clinical trial and support the development of new trials using G207 to treat all types of low-grade and high-grade pediatric and adolescent brain tumors, so that more children have an opportunity to receive this promising therapy in the future.

The best part? All donations received today—up to $50,000—will be DOUBLED by a generous donor.  


At Rally we fund outside the box ideas. We have been funding pediatric brain tumor physician-scientist Dr. Gregory Friedman’s research since 2013. He had an idea for a drug named G207, which is a modified cold sore virus.

We stick with research as long as it is making progress, and Dr. Friedman has made progress indeed.

Last month Dr. Friedman’s promising results were published in the New England Journal of Medicine. His G207 Phase 1 clinical trial that included high grade glioblastoma and anaplastic astrocytoma resulted in a higher quality of life and longer survival rates with mild and infrequent side effects.

The funds raised today will be used for actual next steps needed to move this critical research forward!

Please make a tax-deductible gift today in support of this promising research, so all kids fighting brain cancer have a chance to survive and thrive.

You may also support this exciting campaign by purchasing a commemorative t-shirt with the names of young brain cancer warriors on the back.

Volunteers are the heart of Rally's mission!


Enter your email below to receive details about our volunteer opportunities.

Thank you for your interest in volunteering with Rally! You should receive an email shortly with additional details.